RELATED STUDY
The endocannabinoidome as a substrate for noneuphoric phytocannabinoid action and gut microbiome dysfunction in neuropsychiatric disorders
Key Findings: The authors highlight the role the eCBome plays in the microbiota-gut-brain axis and its association with affective and cognitive functions and in their pathological alterations in neuropsychiatric disorders. In addition, the review focuses on eCBome-based drugs beyond that of THC including CBD, which possess a wide therapeutic window.
Type of Study: Meta-analysis
Study Result: Positive
Research Location(s): Italy
Year of Pub: 2020
Cannabinoids Studied: Cannabidiol (CBD), Tetrahydrocannabinol (THC), Microbiome
Phytocannabinoid Source: Unspecified
Receptors Studied: CB1, CB2
Citation: Di Marzo V. The endocannabinoidome as a substrate for noneuphoric phytocannabinoid action and gut microbiome dysfunction in neuropsychiatric disorders . Dialogues Clin Neurosci. 2020; 22:259-269. doi: 10.31887/DCNS.2020.22.3/vdimarzo
Authors: Di Marzo V
